Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6067)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu HL, Zhao X, Zhang KM, Tang W, Kokudo N. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World J Gastroenterol 2014; 20(34): 12171-12181 [PMID: 25232251 DOI: 10.3748/wjg.v20.i34.12171] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12171.htm |
| Number | Citing Articles |
| 1 |
Paul Stockhammer, Hannah Baumeister, Till Ploenes, Francesco Bonella, Dirk Theegarten, Balazs Dome, Christine Pirker, Walter Berger, Luca Hegedüs, Marcell Baranyi, Martin Schuler, Sophie Deshayes, Servet Bölükbas, Clemens Aigner, Christophe Blanquart, Balazs Hegedüs. Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma. Lung Cancer 2023; 185: 107360 doi: 10.1016/j.lungcan.2023.107360
|
| 2 |
Wenqing Chen, Zhu Zhang, Shiqing Zhang, Peili Zhu, Joshua Ka-Shun Ko, Ken Kin-Lam Yung. MUC1: Structure, Function, and Clinic Application in Epithelial Cancers. International Journal of Molecular Sciences 2021; 22(12): 6567 doi: 10.3390/ijms22126567
|
| 3 |
Lin Zhang, Yanhong Hou, Chunmei Li, Haorun Liu, Yujing Wang. Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo. Arab Journal of Gastroenterology 2022; 23(4): 263 doi: 10.1016/j.ajg.2022.06.005
|
| 4 |
Xiaomin Xi, Jiting Wang, Yue Qin, Weidong Huang, Yilin You, Jicheng Zhan. Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy. Cell Death & Disease 2022; 13(8) doi: 10.1038/s41419-022-05110-2
|
| 5 |
You‐Fan Peng, Hao Lin, Man‐Man Han, Ling Li. Serum carbohydrate antigen 153 and renal function in patients with type 2 diabetes mellitus. Journal of Clinical Laboratory Analysis 2018; 32(7) doi: 10.1002/jcla.22461
|
| 6 |
Jennifer Munkley. The glycosylation landscape of pancreatic cancer (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.9885
|
| 7 |
Tong Xia, Ting Xiang, Hailong Xie. Update on the role of C1GALT1 in cancer (Review). Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13217
|
| 8 |
Chang Feng, Tianshu Chen, Dongsheng Mao, Fan Zhang, Bo Tian, Xiaoli Zhu. Construction of a Ternary Complex Based DNA Logic Nanomachine for a Highly Accurate Imaging Analysis of Cancer Cells. ACS Sensors 2020; 5(10): 3116 doi: 10.1021/acssensors.0c01166
|
| 9 |
Roxana Ulăreanu, Gabriela Chiriţoiu, Florentina Cojocaru, Alexandru Deftu, Violeta Ristoiu, Luciana Stănică, Dan F Mihăilescu, Dana Cucu. N-glycosylation of the transient receptor potential melastatin 8 channel is altered in pancreatic cancer cells. Tumor Biology 2017; 39(10): 101042831772094 doi: 10.1177/1010428317720940
|
| 10 |
Yuming Wang, Xiaodong Liao, Qing Ye, Lei Huang. Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma. Science China Life Sciences 2018; 61(11): 1389 doi: 10.1007/s11427-017-9345-7
|
| 11 |
Qingzhu Liu, Yinxing Miao, Xiaodan Wang, Gaochao Lv, Ying Peng, Ke Li, Ming Li, Ling Qiu, Jianguo Lin. Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors. European Journal of Medicinal Chemistry 2020; 186: 111905 doi: 10.1016/j.ejmech.2019.111905
|